Pathogenesis and damage mechanisms
The development of renal dysfunction in multiple myeloma is directly related to massive proteinuria. The main damaging factor is circulating and freely filtered excess immunoglobulin light chains, known in clinical practice as Bence Jones protein.
The pathogenesis of renal dysfunction is based on two main mechanisms of nephrotoxicity:
- Direct toxic effect. Specific light chain fractions exert a direct damaging effect on renal tubular epithelial cells. This leads to impaired cellular metabolism and reduced viability.
- Tubular obstruction (cast formation). Entering the acidic environment of the tubular fluid, Bence Jones protein actively reacts with Tamm-Horsfall protein, a normal urinary glycoprotein. As a result of their strong binding, large, dense histological casts are formed. They physically block the tubular lumen, causing intra-tubular obstruction and stopping normal urine outflow.
Morphological picture
Morphological changes in Nephropathia myelomatosa predominantly affect the tubulointerstitial apparatus of the kidneys. The main damage mechanism is that protein casts close the tubular lumen, provoking a secondary peritubular inflammatory reaction.
Macroscopic appearance The gross appearance of the kidneys during macroscopic examination does not always have specific features. In the early stages of the disease, the organs usually appear completely normal. However, with a prolonged disease course accompanied by nephron loss and interstitial replacement fibrosis, the kidneys become pale and acquire a characteristic shrunken appearance.
Histological changes (microscopy) A key diagnostic sign upon microscopy is the presence of specific casts that trigger a cascade of destructive reactions:
- Characteristics of casts: With standard staining, they are visualized in the tubules as dense amorphous pink-blue masses. In some cases, protein accumulations form characteristic layered concentric plates. These masses critically distend the tubular lumen.
- Cellular reaction: A specific cellular wall forms around the protein casts; the casts are surrounded by multinucleated giant cells. It has been proven that these cells have a dual origin: they form either from the transformed epithelium of the tubules themselves or from migrated mononuclear phagocytes.
- Destruction of surrounding tissues: Epithelial cells in direct contact with the casts often undergo necrosis. As the pathology progresses, dense protein masses literally "erode" the tubular wall.
- Interstitial inflammation: Upon destruction of the tubular wall and release of its contents into the adjacent interstitium, nonspecific inflammation develops, which over time transforms into a pronounced granulomatous reaction.
Clinical manifestations and comorbidities
Renal damage is recorded in half of patients with multiple myeloma and clinically manifests with several characteristic syndromes.
- Chronic kidney disease (CKD). This is the most frequent clinical scenario. The pathology develops imperceptibly for the patient and progresses very slowly, over many months or even years, gradually reducing the filtration function of the kidneys.
- Acute kidney injury (AKI). In contrast to CKD, it is characterized by a sudden onset. The leading clinical symptom is oliguria (a sharp decrease in urine output), which is often associated with massive single-moment tubular obstruction by protein casts.
- Proteinuria. Increased urinary protein excretion is found in 70% of myeloma patients. It is important to carefully evaluate the nature of proteinuria. If light chains do not predominate in the urine and prominent albuminuria (loss of albumin) is detected, this indicates the addition of other renal filter pathologies.
Concomitant processes In addition to classic cast nephropathy (myeloma kidney), multiple myeloma can be accompanied by the development of other severe lesions. These include secondary AL amyloidosis, membranous nephropathy, and specific glomerulopathy known as light chain deposition disease.
Briefly: answers to topical questions
What factors and environmental conditions in the tubules promote the precipitation of Bence Jones protein and cast formation?
The precipitation of Bence Jones protein and cast formation occurs when immunoglobulin light chains bind to Tamm-Horsfall protein in the acidic tubular environment.
- Bence Jones protein (Bence Jones protein) — immunoglobulin light chains excreted in the urine.
- Tamm-Horsfall protein — a urinary glycoprotein that binds to Bence Jones protein.
- Acidic environment — the tubular condition necessary for this binding reaction.
As a result, large histological tubular casts are formed, obstructing the tubular lumen.
In which specific parts of the nephron (tubules) are protein casts predominantly localized and obstructing the lumen?
Sources only indicate that casts form and locate within the tubules, without specifying the exact segment of the nephron (proximal, distal, collecting ducts).
- Casts — pink-blue amorphous masses in the tubules, dilating the lumen.
- Obstruction mechanism — casts block the tubular lumen, causing a peritubular inflammatory reaction.
Further progression is accompanied by the erosion of the tubular walls by casts and the release of their contents into the interstitium with a granulomatous reaction.
What histological stains are used for the differential diagnosis of protein casts and AL amyloid masses?
Congo red staining with polarized light microscopy is used to diagnose AL amyloid; a separate specific stain for protein casts in myeloma kidney is not specified in the sources.
- Congo red (Congo red) — amyloid stains brick-red.
- Polarized light microscopy — amyloid exhibits apple-green birefringence, unlike collagen and fibrin, which do not show such luminescence.
- Protein casts in myeloma kidney are described histologically as pink-blue amorphous masses without specifying a special differentiating stain.
The rule of two proteins: Bence Jones (the aggressor from the blood) meets Tamm-Horsfall (the local glycoprotein) in an acidic environment — together they build a "dam" (cast) that destroys the kidney.
Class and exam questions
Why do multinucleated giant cells form in myeloma kidney?
They form from tubular epithelium or mononuclear phagocytes as a reaction to foreign protein masses (casts), surrounding them with a peculiar cellular wall in an attempt to isolate or resorb them.
What does the appearance of pronounced albuminuria in a myeloma patient indicate?
This indicates the addition of secondary AL amyloidosis or light chain glomerulopathy, since in classic myeloma kidney, predominantly light chains are lost, not albumin.
How do protein casts destroy renal tissue?
They dilate the tubular lumen, cause necrosis of the surrounding epithelium, and eventually "erode" the wall, spilling into the interstitium where they provoke granulomatous inflammation.
What else to study on this topic
- Mechanisms of direct toxic effect of light chains on tubular epithelium.
- Renal AL amyloidosis as a comorbidity in multiple myeloma.
- Light chain deposition disease (glomerulopathy) and its differences from cast nephropathy.
- Membranous nephropathy in multiple myeloma.
- Differential diagnosis of acute and chronic renal failure in myeloma.
Master the entire topic in the "Pathological Anatomy" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Myeloma kidney" and 4,414 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 153 video lessons on the subject
Other topics in the section "Diseases of the Kidneys and Urinary Tract"
Free video lessons: pathological anatomyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.